INNOVENT BIO (01801) announced that on August 29, 2025, the company granted 20,800 share options to 5 grantees (including independent non-executive director Dr. Sherwin) under the terms of the 2024 Share Plan, subject to acceptance by the grantees. Among the granted share options, 1,800 share options were granted to Dr. Sherwin.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.